Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular weekly insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

China ophthalmology worth USD3.6 bn amid strong burst of growth

Image

 Articles

Rising diagnosis rates, government initiatives, social trends and diabetes are contributing to a strong burst of growth in the ophthalmology market in Asia. Rising numbers of affluent patients, national health insurance and the emerging middle classes are fuelling spending, including a USD3.6 bn market in China, where M&A in the sector is picking up rapidly. [Image: Embassy of PRC]

Read More

US delay in targeting Chinese patients

Image

29-Sep-16 Plans to turn an unused shoe factory in the US city of Auburn, Maine, into a medical tourism centre for Chinese patients are faltering. Chinese investment company Miracle Enterprise plans a 200-room recovery centre for wealthy Chinese seeking medical care at the Central Maine Medical Center. Miracle Enterprise needs to find USD40 mn, but is struggling to attract investors. [image: IMTJ]

Read More

Philippines seeks bigger share in global medical-tourism market

Image

29-Sep-16 The Philippines is poised to take advantage of the global medical tourism market, positioning itself as a provider of excellent and affordable hospital care. The country’s advantages include modern facilities, fluency in English, good infrastructure, proximity to Asia’s major cities, “and the ability of a caring local community to help in total healing in body, mind and spirit.” [image: Department of Tourism, Philippines]

Read More

China’s USD5 bn healthcare deal spree

Image

29-Sep-16 Chinese companies have announced more than USD5.2 bn of overseas healthcare acquisitions in 2016, a 15-fold jump from 2012. "Even though China’s pharmaceutical industry is still in the middle of consolidation and price wars, we hope to escape from this and do more work in terms of innovation and internationalization," said Shao Yan, CEO of China Grand Pharma. [image: China Grand Pharmaceutical and Healthcare Holdings Ltd]

Read More
Share